2022 Savings Offer for AJOVY is here. Learn more

A LIFE IN MOTION DEMANDS LESS MIGRAINE

The long-acting anti-CGRP
injection with lasting protection against migraine1*

*”Long-acting” and ”lasting protection” defined as reduction in monthly average migraine or headache days measured over a 12-week period following a monthly 225 mg SC dose or quarterly 675 (225 mg x 3) SC dose.1†